Recombinant 40S ribosomal protein S3a (LbrM34_V2.0430, LbrM_34_0430)

Shipped with Ice Packs
In Stock

Description

Expression and Purification

Recombinant LbrM34_V2.0430 is produced via heterologous expression in yeast, a system chosen for its ability to perform eukaryotic post-translational modifications while maintaining high yield . Alternative systems like Escherichia coli or insect cells are also viable but may lack specific modifications critical for functional studies .

Key Steps in Production

  • Cloning: The gene is inserted into a yeast expression vector under a strong promoter.

  • Fermentation: Optimized for high-density growth to maximize protein yield.

  • Purification: Affinity chromatography (e.g., Ni-NTA for His-tag purification) followed by size-exclusion chromatography.

DNA Repair and Apoptosis

  • Human RPS3a interacts with NF-κB to regulate pro-inflammatory gene transcription .

  • Phosphorylation by kinases like ERK1 and PKCδ modulates its nuclear translocation and DNA repair activity .

Immune Modulation

  • Human RPS3 binds Toll-like receptor 4 (TLR4) to activate dendritic cells, suggesting potential adjuvant applications in vaccines .

  • Pathogens like enteropathogenic E. coli (EPEC) exploit RPS3 interactions to suppress host immune responses .

Table: Potential Uses of Recombinant LbrM34_V2.0430

ApplicationRationale
Drug Target ScreeningStudy interactions with Leishmania-specific inhibitors.
Structural BiologyElucidate ribosome architecture in parasitic protozoa.
Vaccine DevelopmentExplore TLR4-mediated immune activation pathways .
Host-Pathogen InteractionInvestigate ribosomal hijacking mechanisms during infection.

Challenges and Future Directions

  • Species-Specific Variability: Functional insights from human or yeast RPS3a may not fully translate to L. braziliensis due to evolutionary divergence.

  • Post-Translational Modifications: Yeast-derived protein may lack parasite-specific modifications, necessitating insect or mammalian systems for certain studies .

Product Specs

Form
Lyophilized powder. We will preferentially ship the available format. If you have specific format requirements, please note them when ordering, and we will accommodate your request.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for specific delivery details. All proteins are shipped with standard blue ice packs. If dry ice is required, please contact us in advance; additional charges apply.
Notes
Avoid repeated freezing and thawing. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect the contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. Adding 5-50% glycerol (final concentration) is recommended for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on several factors: storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form is stable for 6 months at -20°C/-80°C, while the lyophilized form is stable for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process. If you require a specific tag type, please inform us, and we will prioritize its development.
Synonyms
LbrM34_V2.0430; LbrM_34_0430;; LbrM34_V2.0440; LbrM_34_0440; 40S ribosomal protein S3a
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
2-264
Protein Length
Full Length of Mature Protein
Purity
>85% (SDS-PAGE)
Species
Leishmania braziliensis
Target Names
LbrM34_V2.0430
Target Protein Sequence
ALGKNKRIS KGGKRGKRGK AQETMARKEW YDVVAPSNFE KRQFSKTICN KTQGTRIAAD VLRGRVFEAN LADLNQSAGE EEAYRKVRFT VQEVQGRNLL TQFHSMEMTT DKMASLLRKW CTTMETTVEV RTADGYTMRL FVVAFTKPQA NQQSRNCYAK QRLVKWLRMR VTKMIKRRLS KVQIKEAVSL LTRNVLSDAL VRRCNPIVPL REMRIRKVRV VRTPKFDAQA LLNAHGTIPT SVEADPREVE EAVEAAPAAA KAAE
Uniprot No.

Target Background

Database Links
Protein Families
Eukaryotic ribosomal protein eS1 family
Subcellular Location
Cytoplasm.

Q&A

Basic Research Questions

  • What is the function and structure of 40S ribosomal protein S3a in Leishmania braziliensis?

    Ribosomal protein S3a in Leishmania braziliensis functions primarily as a component of the 40S ribosomal subunit, participating in protein synthesis. Based on structural homology with other eukaryotic S3a proteins, it likely plays roles in ribosome assembly, mRNA binding, and translation initiation. The protein belongs to the S3AE family of ribosomal proteins and is located in the cytoplasm . Similar to its human homolog, it may participate in the initiation phase of translation by helping to stabilize ribosome structure. Beyond canonical functions, ribosomal proteins in trypanosomatids often possess "moonlighting" or extra-ribosomal functions involved in RNA processing, DNA repair, or other cellular processes.

    The protein structure can be predicted through homology modeling using related structures, which typically reveals an RNA-binding domain characteristic of the S3AE family. Experimental determination using X-ray crystallography or cryo-electron microscopy would provide definitive structural data.

  • How is the gene encoding 40S ribosomal protein S3a organized in the Leishmania braziliensis genome?

    The gene encoding 40S ribosomal protein S3a in L. braziliensis (LbrM34_V2.0430 or LbrM_34_0430) is located on chromosome 34, as indicated by its identifier . The genomic organization can be analyzed through bioinformatic approaches using available genome sequences. Like other protein-coding genes in Leishmania, it is likely organized in a polycistronic transcription unit, as Leishmania genes are typically transcribed as polycistronic pre-mRNAs that are subsequently processed into individual mRNAs through trans-splicing and polyadenylation.

    To experimentally determine the exact gene structure, researchers should employ:

    • Genomic DNA sequencing to confirm the coding sequence

    • 5' and 3' RACE (Rapid Amplification of cDNA Ends) to identify untranslated regions

    • RT-PCR to verify the transcript structure

    • RNA-Seq analysis to identify potential alternative splicing events

  • What expression systems are optimal for producing recombinant 40S ribosomal protein S3a from Leishmania braziliensis?

    Producing recombinant 40S ribosomal protein S3a from L. braziliensis requires careful selection of expression systems and optimization of conditions. Based on research with similar ribosomal proteins, the following methodological approach is recommended:

    a. Vector Selection:

    • pET vectors (pET-28a) with N-terminal His-tag for IMAC purification

    • pGEX vectors for GST-fusion to enhance solubility

    • pMAL vectors for MBP-fusion to improve folding

    b. Expression Hosts:

    • E. coli BL21(DE3) for standard expression

    • E. coli Rosetta for optimizing rare codons found in Leishmania

    • Leishmania tarentolae for expression with native post-translational modifications

    c. Optimization Parameters:

    • Temperature: Test 16°C, 25°C, and 37°C (lower temperatures often improve folding)

    • Induction: IPTG concentrations from 0.1-1.0 mM

    • Duration: 4 hours to overnight expression

    • Media: LB, TB, or auto-induction media

    d. Solubility Enhancement:

    • Co-expression with chaperones (GroEL/GroES)

    • Addition of solubilization agents (0.1% Triton X-100, 5-10% glycerol)

    • Use of multiple fusion tags (His-SUMO, His-Trx)

  • What methods are used to analyze the purity and functionality of recombinant 40S ribosomal protein S3a?

    After expression and purification, comprehensive characterization of the recombinant protein ensures quality and functionality:

    a. Purity Assessment:

    • SDS-PAGE with Coomassie or silver staining (target: >95% purity)

    • Size exclusion chromatography to analyze aggregation state

    • Capillary electrophoresis for high-resolution analysis

    b. Identity Confirmation:

    • Western blotting with anti-His tag or specific antibodies

    • Mass spectrometry (MALDI-TOF or LC-MS/MS) for precise molecular weight and peptide mapping

    • N-terminal sequencing to confirm the correct protein sequence

    c. Structural Analysis:

    • Circular dichroism spectroscopy to assess secondary structure content

    • Thermal shift assay to evaluate protein stability

    • Dynamic light scattering to determine size distribution

    d. Functional Assays:

    • RNA binding assays (EMSA, filter binding)

    • In vitro translation assays with depleted ribosomes

    • Ribosome assembly assays to test incorporation into 40S subunits

Advanced Research Questions

  • How do post-translational modifications influence the function of 40S ribosomal protein S3a in Leishmania braziliensis?

    Post-translational modifications (PTMs) can significantly alter protein function, localization, and interactions. For L. braziliensis S3a, a systematic approach to study PTMs involves:

    a. PTM Identification:

    • High-resolution mass spectrometry (LC-MS/MS) with enrichment strategies for specific modifications

    • Phosphoproteomics using TiO₂ or IMAC enrichment for phosphorylation sites

    • Complementary fragmentation methods (HCD, ETD) to improve PTM detection

    b. Site-specific Analysis:

    • Generate site-directed mutants (Ser/Thr/Tyr to Ala for phosphorylation)

    • Create phosphomimetic mutants (Ser/Thr to Asp/Glu)

    • Employ synthetic peptides with defined modifications for functional studies

    c. Temporal Dynamics:

    • Analyze PTM changes across parasite lifecycle stages

    • Examine PTM responses to stress conditions (oxidative, temperature, pH)

    • Study PTM changes during host cell infection

    d. Functional Consequences:

    • Assess effects on RNA binding affinity and specificity

    • Evaluate impact on protein-protein interactions within the ribosome

    • Determine influence on extra-ribosomal functions and localization

    The LC-MS-based approach used to study lipid modifications in Daphnia magna provides a methodological framework that could be adapted for studying PTMs in Leishmania proteins.

  • What role does 40S ribosomal protein S3a play in Leishmania braziliensis stress response and adaptation?

    Understanding how S3a contributes to stress response requires multiple experimental approaches:

    a. Expression Analysis Under Stress:

    • qRT-PCR and Western blotting to quantify changes in mRNA and protein levels

    • Polysome profiling to assess translation efficiency of S3a mRNA

    • Subcellular localization studies using immunofluorescence or fractionation

    b. Genetic Manipulation Approaches:

    • Generate conditional knockdown using tetracycline-inducible systems

    • Create parasites overexpressing wild-type or mutant S3a

    • Implement CRISPR-Cas9 for precise gene editing to modify specific domains

    c. Phenotypic Characterization:

    • Assess growth kinetics under various stressors (oxidative, temperature, pH, nutrient)

    • Measure survival during macrophage infection

    • Evaluate morphological changes associated with differentiation

    d. Molecular Mechanisms:

    • Identify stress-specific interacting partners through co-immunoprecipitation

    • Perform RNA immunoprecipitation (RIP) to identify bound transcripts

    • Use ribosome profiling to assess global translation changes

    As ribosomal proteins often relocalize during stress responses, fluorescent tagging of S3a could reveal dynamic changes in localization that correlate with adaptation to different environmental conditions.

  • How does the interaction network of 40S ribosomal protein S3a differ between Leishmania braziliensis and human cells?

    Comparative interactomics provides insights into parasite-specific interactions that could be targeted therapeutically:

    a. Experimental Interactome Mapping:

    • Affinity purification-mass spectrometry (AP-MS) with tagged S3a

    • BioID or APEX proximity labeling to capture transient interactions

    • Yeast two-hybrid screening against L. braziliensis and human cDNA libraries

    b. Computational Prediction Methods:

    • Structural modeling of interaction interfaces

    • Coevolution analysis to identify co-varying residues

    • Network-based predictions using ortholog information

    c. Validation Approaches:

    • Co-immunoprecipitation of predicted interactors

    • Bimolecular fluorescence complementation (BiFC) for in vivo validation

    • Mutation of key interface residues to disrupt specific interactions

    d. Comparative Analysis:

    • Cross-species conservation of interactions

    • Parasite-specific interactions absent in human cells

    • Differential binding affinities for conserved interactions

    The STRING database indicates that Leishmania ribosomal proteins have high-confidence interactions with other ribosomal components , but parasite-specific extra-ribosomal interactions remain largely unexplored.

  • What structural features distinguish Leishmania braziliensis 40S ribosomal protein S3a from its human homolog?

    Identifying structural differences requires integrative structural biology approaches:

    a. Sequence-based Analysis:

    • Multiple sequence alignment of S3a across species

    • Conservation mapping to identify parasite-specific residues

    • Disorder prediction to identify flexible regions

    b. Structural Determination:

    • X-ray crystallography or cryo-EM of isolated proteins

    • Structure determination within assembled ribosomes

    • Homology modeling if experimental structures are unavailable

    c. Structural Comparison:

    • Superposition of parasite and human structures

    • Analysis of electrostatic surface potential

    • Identification of parasite-specific pockets or interfaces

    d. Functional Implications:

    • Molecular dynamics simulations to assess conformational dynamics

    • Docking studies with RNA and protein partners

    • Virtual screening against parasite-specific structural features

    A comprehensive structural comparison would reveal targetable differences that could be exploited for the development of selective inhibitors that disrupt S3a function in the parasite without affecting the human homolog.

Research Methodologies

  • What CRISPR-Cas9 strategies are effective for studying the essentiality of 40S ribosomal protein S3a in Leishmania braziliensis?

    CRISPR-Cas9 approaches for studying essential genes require careful design and conditional systems:

    a. sgRNA Design and Delivery:

    • Design multiple sgRNAs targeting exonic regions of LbrM34_V2.0430

    • Optimize for minimal off-target effects using LeishGEdit tools

    • Deliver as ribonucleoprotein complexes via nucleofection

    b. Conditional Systems:

    • DiCre-loxP system for inducible deletion

    • Auxin-inducible degron (AID) for protein-level depletion

    • Tetracycline-regulatable expression systems

    c. Donor Template Design:

    • Homology arms (≥500 bp) flanking the target region

    • Selectable markers (hygromycin, neomycin, puromycin resistance)

    • Fluorescent reporters for phenotypic screening

    d. Validation Approaches:

    • PCR and sequencing to confirm genomic modifications

    • Western blotting to verify protein depletion

    • Growth curve analysis to assess fitness effects

    e. Rescue Experiments:

    • Complementation with wild-type gene

    • Expression of mutant variants to identify essential domains

    • Heterologous expression of human S3a to test functional conservation

    As ribosomal proteins are generally essential, establishing conditional systems prior to disruption attempts is strongly recommended to prevent selective pressure against editing events.

  • How can computational approaches predict the impact of mutations in 40S ribosomal protein S3a on Leishmania braziliensis fitness?

    Computational methods provide powerful tools for predicting mutation effects:

    a. Sequence-based Predictions:

    • Conservation analysis across Leishmania species

    • Evolutionary coupling analysis to identify co-evolving residues

    • Machine learning models trained on known deleterious mutations

    b. Structure-based Assessments:

    • Molecular dynamics simulations of mutant proteins

    • Free energy calculations to quantify stability changes

    • Analysis of effects on protein-protein and protein-RNA interfaces

    c. Network-level Predictions:

    • Perturbation analysis of protein interaction networks

    • Metabolic modeling to predict growth defects

    • Gene expression network analysis for compensatory mechanisms

    d. Integrative Approaches:

    • Ensemble methods combining multiple predictors

    • Statistical coupling with experimental fitness data

    • Bayesian networks incorporating diverse evidence types

    e. Validation Design:

    • Prioritization of mutations for experimental testing

    • Systematic mutagenesis strategies (alanine scanning, deep mutational scanning)

    • Cross-species comparative validation

    These approaches can guide experimental design by identifying high-priority mutations likely to affect parasite fitness without impacting the human ortholog.

Research Applications and Data

  • What is the comparative sequence analysis of Leishmania braziliensis 40S ribosomal protein S3a across trypanosomatids?

    Comparative sequence analysis provides evolutionary insights and identifies conserved functional regions:

    SpeciesSequence Identity to L. braziliensis S3a (%)Length (aa)Key Differences
    L. braziliensis100~265*Reference sequence
    L. major~95*~265*Variations in N-terminal region
    L. infantum~95*~265*Variations in surface loops
    L. donovani~95*~265*Conservative substitutions
    T. cruzi~80*~270*Extended C-terminal domain
    T. brucei~80*~270*Insertions in RNA-binding region
    Human~60*264Divergent surface loops and N-terminus

    *Approximate values based on typical conservation patterns in ribosomal proteins

    The highest conservation occurs in the RNA-binding domains and interaction surfaces with other ribosomal proteins, while surface-exposed regions show greater variability. Trypanosomatid-specific sequence features include unique insertions and extensions not found in mammalian homologs, which could be exploited for selective targeting.

  • How does 40S ribosomal protein S3a expression vary across Leishmania braziliensis life cycle stages?

    Life cycle-specific regulation provides insights into adaptation mechanisms:

    a. Transcriptomic Analysis Methods:

    • RNA-Seq of procyclic promastigotes, metacyclic promastigotes, and amastigotes

    • qRT-PCR with stage-specific biological replicates

    • Analysis of transcript stability using actinomycin D chase experiments

    b. Proteomic Approaches:

    • Quantitative proteomics (SILAC, TMT, or label-free)

    • Western blotting with stage-specific lysates

    • Polysome profiling to assess translation efficiency

    c. Post-translational Regulation:

    • Phosphoproteomics across life cycle stages

    • Analysis of protein turnover rates

    • Assessment of subcellular localization changes

    d. Expected Patterns:

    • Based on studies in related species, S3a protein levels might remain relatively constant

    • Post-translational modifications likely vary between stages

    • Localization may change from primarily ribosomal to multiple cellular compartments

    Understanding stage-specific expression patterns could reveal critical periods when the parasite is most vulnerable to disruption of S3a function.

  • What are the best methodologies for assessing 40S ribosomal protein S3a interactions with host factors during infection?

    Identifying host-parasite protein interactions requires specialized approaches:

    a. In vitro Interaction Screening:

    • Recombinant S3a pull-down with host cell lysates

    • Protein microarrays probed with labeled S3a

    • Yeast two-hybrid screening against human cDNA libraries

    b. In vivo Approaches:

    • Proximity labeling (BioID, APEX) in infected cells

    • Crosslinking immunoprecipitation (CLIP) for RNA interactions

    • FRET/BRET-based interaction detection systems

    c. Functional Validation:

    • Heterologous expression of S3a in mammalian cells

    • Mutation of interaction interfaces in S3a

    • siRNA knockdown of putative host interactors

    d. Imaging Methods:

    • Super-resolution microscopy for co-localization

    • Live-cell imaging of fluorescently tagged proteins

    • Correlative light and electron microscopy for ultrastructural context

    e. Bioinformatic Prediction:

    • Host-pathogen interaction databases

    • Interface prediction algorithms

    • Molecular docking of S3a with candidate host proteins

    These methodologies can identify potential host targets that interact with S3a during infection, which might represent intervention points for therapeutic development.

  • How can high-throughput screening approaches identify selective inhibitors of Leishmania braziliensis 40S ribosomal protein S3a?

    Developing selective inhibitors requires systematic screening strategies:

    a. Assay Development:

    • Fluorescence polarization assays for RNA binding

    • AlphaScreen for protein-protein interaction disruption

    • Cellular assays using reporter constructs

    b. Screening Libraries:

    • Natural product collections (especially from plants with anti-leishmanial activity)

    • Synthetic fragment libraries targeting RNA-binding proteins

    • Repurposing libraries of clinically tested compounds

    c. Structure-based Approaches:

    • Virtual screening against parasite-specific pockets

    • Fragment-based screening with NMR or X-ray crystallography

    • Design of peptidomimetics targeting protein-protein interfaces

    d. Validation Cascade:

    • Secondary biochemical assays

    • Parasite and mammalian cell viability assays

    • Target engagement studies in parasites

    • Mechanism of action studies (transcriptomics, proteomics)

    e. Lead Optimization:

    • Structure-activity relationship studies

    • Medicinal chemistry optimization for selectivity

    • ADME and pharmacokinetic improvements

    The ideal screening approach would integrate computational and experimental methods, focusing on parasite-specific structural features to achieve selectivity.

  • What future research directions will advance our understanding of 40S ribosomal protein S3a function in Leishmania braziliensis?

    Several promising research avenues could transform our understanding:

    a. Single-cell Technologies:

    • Single-cell RNA-Seq to identify heterogeneity in expression

    • Single-cell proteomics to analyze protein levels in individual parasites

    • Live-cell single-molecule tracking of S3a dynamics

    b. Systems Biology Approaches:

    • Integration of multi-omics data (genomics, transcriptomics, proteomics)

    • Network analysis of S3a interactors across conditions

    • Computational modeling of ribosome assembly and function

    c. Structural Biology Innovations:

    • Cryo-electron tomography of intact parasites

    • Time-resolved structural studies of ribosome assembly

    • Integrative structural biology combining multiple data types

    d. Translational Applications:

    • Development of S3a-targeted therapeutics

    • Exploration of S3a as a vaccine candidate

    • Design of diagnostic tools based on species-specific features

    e. Evolutionary Studies:

    • Comparative analysis across Leishmania clinical isolates

    • Adaptation patterns in drug-resistant strains

    • Horizontal gene transfer and evolutionary pressure analysis

    These directions reflect the integration of cutting-edge technologies with fundamental biological questions, promising to advance both basic understanding and applied interventions for leishmaniasis.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.